Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Angiodynamics Inc Completes Acquisition Of Assets Of Microsulis Medical Ltd
Angiodynamics Inc announced that it has completed the previously announced acquisition of certain assets of Microsulis Medical Ltd. Terms of the transaction were not disclosed.
Latest Developments for AngioDynamics Inc
- FDA Grants Prostate IDE Approval For Angiodynamics Inc's NanoKnife System
- Angiodynamics Inc Lowers FY 2013 Guidance
- Angiodynamics Inc Issues Q3 2013 Guidance Below Analysts' Estimates
- Angiodynamics Inc Sees FY 2013 Revenue Guidance To A Slightly Lower Midpoint Of Prior Range; Reaffirms FY 2013 EPS Guidance-Conference Call
Latest Key Developments in Medical
- MIT Capital Inc Proposes To Acquire Meade Instruments Corp For $3.65 Per Share In Cash
- FDA Grants Prostate IDE Approval For Angiodynamics Inc's NanoKnife System
- Urban Ag Corp Announces It Has Entered Into The Final Stages Of Negotiations To Acquire Contractor Currently Generating $4,500,000 In Revenues
- HeartWare International Inc Receives Conditional Approval From FDA To Enroll Supplemental Patient Cohort In Destination Therapy Trial
- Share this
- Link this
- Digg this
Follow Reuters